Ann Arbor, MI, United States of America

Nicole Chantel Barvian


 


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Nicole Chantel Barvian

Introduction

Nicole Chantel Barvian is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 8 patents to her name, Barvian's work has the potential to impact various medical conditions.

Latest Patents

Among her latest patents, Barvian has developed isophthalic acid derivatives as matrix metalloproteinase inhibitors. These selective MMP-13 inhibitors are crucial in treating diseases related to inflammation and cancer. Additionally, she has worked on benzoxazin-3-ones and derivatives as therapeutic agents, providing compounds that are useful in treating inflammatory diseases, cardiovascular diseases, and cancers. These inventions also include pharmaceutical compositions that comprise one or more of these innovative compounds.

Career Highlights

Barvian is currently associated with Warner-Lambert Company, where she continues to push the boundaries of pharmaceutical research. Her work has garnered attention for its potential applications in treating serious health conditions.

Collaborations

Throughout her career, Barvian has collaborated with notable colleagues, including William Chester Patt and David T Connor. These partnerships have further enhanced her research and development efforts.

Conclusion

Nicole Chantel Barvian's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. Her patents and ongoing research continue to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…